ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,345.41
-0.84%
Dow Jones
39,850.92
-0.06%
Gold vs US Dollar
2,390.09
-1.29%
Brent Oil
82.195
-0.30%
Bitcoin
70,120.73
-0.02%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Syndax Pharmaceuticals Inc (SNDX) Share Price

SNDX Syndax Pharmaceuticals Inc

20.72
0.06 (0.29%)
Last Updated: 15:48:00
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Syndax Pharmaceuticals Inc NASDAQ:SNDX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.06 0.29 20.72 20.71 20.73 20.805 20.57 20.67 77,457 14:48:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -209.36M -2.4641 -8.42 1.76B
 Type  Size  Price  Time  Units 
 9 20 20.7001 14:49:26 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore SNDX News
16/05/202421:04EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
16/05/202421:03EDGAR2Form 3 - Initial statement of beneficial ownership of securities
15/05/202421:11EDGAR2Form 8-K - Current report
15/05/202421:05PRNUSSyndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
09/05/202412:00PRNUSSyndax Announces Participation at the Bank of America Securities 2024 Health Care Conference
08/05/202412:06PRNUSSyndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
08/05/202412:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Period
Draw mode
Data Downloads for SNDX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Syndax Pharmaceuticals Inc Articles